
Weighing Up Diet Drugs
Newscast
00:00
Semaglutide: From Diabetes Treatment to Weight Loss Wonder Drug
The chapter explores the drug Semaglutide, highlighting its potential 20% reduction in heart attack or stroke risk. It delves into its journey from a diabetes treatment to a popular weight loss drug, discussing the regulatory challenges in prescribing such medications in the UK NHS. The chapter also addresses concerns around prescribing drugs outside of licenses and the skepticism surrounding a study funded by Novo Nordisk, emphasizing the importance of further research for validation.
Transcript
Play full episode